United We TransformCreate teamsGrade your agenda
Atlas/Events/AHA Scientific Sessions - Archive -...
action-oriented convening agenda analysis

AHA Scientific Sessions - Archive - Selected Science News from AHA21

This action-oriented convening in Academic / Research / Science shows 23 visible agenda rows from professional.heart.org and scores 32/100: a thin but inspectable design signal. The clearest public signals sit in Learning Transfer and Problem Specificity; the main limits are Follow Through and Network Design. Visible mechanisms include Participant work, Commitments, Feedback, and Network design. Follow-through or tracking is at least visible enough to inspect, though causal proof still depends on stronger evidence. A practical reading: For a reader, this is a comparison record more than a model to copy: it reads as an action-oriented convening, with the strongest visible signal in learning transfer and problem specificity and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence. This page is an original public-evidence analysis, not a copy of the source agenda or an endorsement of the event. The score places the visible agenda in the thin outcome architecture band. The strongest visible pillars are Learning Transfer, Problem Specificity, and Evidence Maturity; the thinnest visible pillars are Network Design, Follow Through, and Participation Architecture. Visible mechanisms include Participant work, Commitments, Feedback, Network design, and Learning transfer. The extracted agenda preview includes 43 visible rows. The most common formats are Presentation, Unknown, and Training; the most common inferred purposes are Knowledge Transfer, Unknown, and Skill Building.

Primary source evidence: professional.heart.org ↗ · Archived copy (2026-01-18)

Eight-pillar fingerprint

Hover any pillar to see what it measures and, where it scored low, what the agenda is missing.

Participation Architecture?29
Participation Architecture - 29/100. Participant work, contribution, interaction, and alternatives to passive broadcast.Missing: Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.
Follow Through?16
Follow Through - 16/100. Owners, dates, commitments, progress checks, and accountability after the room.Missing: Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
Problem Specificity?39
Problem Specificity - 39/100. A clear costly problem, objective, decision, or performance target.
Personalization?31
Personalization - 31/100. Role, path, goal, preparation, or connection tailoring for participants.
Network Design?16
Network Design - 16/100. Structured weak ties, bridge-building, mixers, and relationship persistence.Missing: Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
Learning Transfer?47
Learning Transfer - 47/100. Applied practice, feedback, workplace use, refreshers, and 30-90 day transfer.
Evidence Maturity?38
Evidence Maturity - 38/100. Baseline, comparison, follow-up, isolation, and attribution confidence.
Future-of-Work Fit?33
Future-of-Work Fit - 33/100. Value against time, hybrid reality, accessibility, AI, and meeting load.

Fix the gaps

Field-tested exercises matched to this agenda's weakest pillars, from the exercise library.

Follow Through (16/100)

Exercises that strengthen it: Mental Toughness Workshop • WorkshopBank · 15% Solutions • WorkshopBank · Network Patches

Participation Architecture (29/100)

Exercises that strengthen it: Make A World · Awestruck 3 Minutes · Spectrum Mapping

Agenda Preview

The actual agenda we captured. Every block is classified by format and purpose. Open any block to see how we read it; the colored edge shows whether it is participant work, broadcast, logistics, or a showcase.

Room vs wrapper

9 percent of the 43 classified blocks put participants to work; the rest broadcast, show, or handle logistics. That mix is what drives the participation score.

4
36
1
2
Participant workBroadcastShowcaseLogistics
10:00 AMRegister for the CKM Syndrome Guideline Unpacked Virtual Summit, June 30 at CDT.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventStroke Guideline Training ModulesTrainingSkill building+
Format · Participant workTrainingGuided skill building where participants practice. Counts as participant work and learning transfer.
Evidence basisParticipant work is implied by the formatInferred from format
all eventFellows in Training (FIT)TrainingSkill building+
Format · Participant workTrainingGuided skill building where participants practice. Counts as participant work and learning transfer.
Evidence basisParticipant work is implied by the formatInferred from format
all eventA still image from the Video: AHA21 Highlights.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventVideo still showing the background data points of the AVATAR trialPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventStill shot from James Gammie's live presentationPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventVideo still frame showing Jiang He, MD, PhD, investigator for the Chinese Rural Hypertension Control Project.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all event![Scientific Sessions DAILY NEWS - Keep your finger on the pulse of Scientific Sessions 2021. View Today's HeadlinesPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventA video still frame showing Gregory M. Marcus, MD, MAS as he explains the methodology and results of the CRAVE trial.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventStill shot from Mario Gaudino's live presentationPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventVideo still of David J. Wilber, MD, FAHA, FACC, FHRS discussing results of the aMAZE trial.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventA video still from of Steven A Lubitz, MD, of Massachusetts General Hospital, as he discusses the Fitbit Heart study.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventA still frame showing Gregory M Marcus, MD, and his explanation about the I-STOP AF trial, presented at Scientific Sessions 2021.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventA still frame from a video about the EMPULSE trial, presented at Scientific Sessions 2021.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventA still frame from the #ReSS21 Program Highlights, with Benjamin S. Abella, MD, MPhil and Michael W. Donnino, MD.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventQCOR21 Program Highlights - still shot of videoPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventStill from video about results of PREPARE-IT 2.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
all eventStill frame from video of Jane M Armitage, PI for ASCEND video.PresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
7 a.m. - 7 p.mMonday - Friday: . CTPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
9 a.m. - 5 p.mSaturday: . CTPresentationKnowledge transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisNo participant output visible from this rowRead from source, no work signal
10:00 AMRegister for the CKM Syndrome Guideline Unpacked Virtual Summit, June 30 at CDT.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
all eventStroke Guideline Training ModulesTrainingSkill Building+
Format · Participant workTrainingGuided skill building where participants practice. Counts as participant work and learning transfer.
Evidence basisMediumRead from source
all eventFellows in Training (FIT)TrainingSkill Building+
Format · Participant workTrainingGuided skill building where participants practice. Counts as participant work and learning transfer.
Evidence basisMediumRead from source
all eventAHA21 Science News coverage brings you results and insights into this year's Tier 1 late-breaking cardiovascular science trials presented at Scientific Sessions 2021. Find at-a-glance data summaries, exclusive interviews, simultaneous publications, and more - all in one place.BreakWellbeing+
Format · LogisticsBreakA pacing or recovery block between sessions.
Evidence basisMediumRead from source
all eventA still image from the Video: AHA21 Highlights.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventAnother exciting Scientific Sessions conference is in the books! Don Lloyd-Jones, Manesh Patel, Amit Khera, and Tracy Wang highlight some of the top sessions and late breaking science presented during #AHA21 this year. Don't forget to scroll down for a deeper look into this year's Tier 1 trials, as well as links to simultaneously published articles.BreakWellbeing+
Format · LogisticsBreakA pacing or recovery block between sessions.
Evidence basisMediumRead from source
all eventVideo still showing the background data points of the AVATAR trialUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventStill shot from James Gammie's live presentationPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventVideo still frame showing Jiang He, MD, PhD, investigator for the Chinese Rural Hypertension Control Project.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event![Scientific Sessions DAILY NEWS - Keep your finger on the pulse of Scientific Sessions 2021. View Today's HeadlinesPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventA video still frame showing Gregory M. Marcus, MD, MAS as he explains the methodology and results of the CRAVE trial.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventStill shot from Mario Gaudino's live presentationPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventPublished in The Lancet : Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial (opens in new window)02490-9/fulltext)Poster SessionShowcase+
Format · ShowcasePoster SessionPresenters display work; attendees browse and ask questions. Some interaction, not structured work.
Evidence basisMediumRead from source
all eventVideo still of David J. Wilber, MD, FAHA, FACC, FHRS discussing results of the aMAZE trial.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventA video still from of Steven A Lubitz, MD, of Massachusetts General Hospital, as he discusses the Fitbit Heart study.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventA still frame showing Gregory M Marcus, MD, and his explanation about the I-STOP AF trial, presented at Scientific Sessions 2021.PresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventA still frame from a video about the EMPULSE trial, presented at Scientific Sessions 2021.PresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventA still frame from the #ReSS21 Program Highlights, with Benjamin S. Abella, MD, MPhil and Michael W. Donnino, MD.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventQCOR21 Program Highlights - still shot of videoUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventStill from video about results of PREPARE-IT 2.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventStill frame from video of Jane M Armitage, PI for ASCEND video.UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
7 a.m. - 7 p.mMonday - Friday: . CTUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source
9 a.m. - 5 p.mSaturday: . CTUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisMediumRead from source

The Full Reading

Why It Ranks This Way +

Calibrated from GES design 31/100 and verified 31/100 with no fourth-loop cap.

Reader Takeaway. For a reader, this is a comparison record more than a model to copy: it reads as an action-oriented convening, with the strongest visible signal in learning transfer and problem specificity and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence.

Strongest signals: Learning Transfer, Problem Specificity, and Evidence Maturity. Weakest signals: Network Design, Follow Through, and Participation Architecture.

How This Agenda Could Improve +
  • Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
  • Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
  • Turn passive airtime into participant work: practice, sensemaking, decisions, critique, or artifact creation.

Fastest next move: Add named owners, dated next steps, and a visible continuation path before treating the event as outcome-ready.

Role-Specific Reading +

Event owner lens

Use this record to benchmark whether a comparable event makes the work after the room visible. The score is 32/100, so the next move is to benchmark the weakest pillars before repeating the format.

Sponsor lens

Look beyond exposure. Strong sponsor value would show qualified interaction, problem work, buyer learning, customer evidence, or follow-up. The practical sponsor move is to look for structured introductions, buyer-seller fit, and relationship persistence.

Designer lens

The agenda is useful as a pattern sample from professional.heart.org. Redesign attention should go first to the lowest-scoring pillars; in practice, turn the thinnest agenda blocks into participant work.

Executive lens

Treat the visible agenda as an operating plan. The executive move is to require owners, dates, and evidence before treating the event as strategic. If owners, proof, and follow-through are not visible, the public record does not yet prove strategic movement.

Aggregator lens

Treat the source URL as evidence, not decoration. The data-product move is to label the source boundary clearly before ranking the record before ranking or syndicating the record.

What GES Means Here +

The Gathering Effectiveness Score is a strict 0-100 public-evidence reading of the agenda across eight pillars. It rewards visible participant work, follow-through, transfer, network design, and proof mechanisms more than polish, speaker fame, attendance, or satisfaction.

Visible mechanisms: Participant work, Commitments, Feedback, Network design, Learning transfer, Personalization.

Evidence boundary: Scores reflect visible agenda/source evidence and should not be read as proof of causal event impact.

Limitations, Score Caps, and Review Flags +

Limitations

  • Passive stage formats dominate the visible agenda.
  • No baseline measurement is visible.

Score caps

  • No fourth-loop score cap applied.

Review flags

  • No tracking, validation, feedback, or impact measurement found in the visible source text.
Is this proof the event worked? +

No. This is a strict public-evidence reading of the agenda. Proof would require baseline, comparison, follow-up, attribution, and impact evidence beyond the listing.

What should a reader inspect first? +

Start with the source URL, then compare the eight pillar scores against the agenda rows. The biggest opportunities usually sit in follow-through, evidence maturity, and participant work.

Why publish weak records? +

Weak records are part of the map. They show where public agendas still describe sessions and speakers more often than outcomes, commitments, transfer, or proof.

How should I use the rows? +

Read the agenda rows as the visible design trace: formats, purposes, and evidence labels show what the public source made inspectable, not everything that happened in the room. This is a source-grounded interpretation of the public agenda record, not a copy of the source, and not an endorsement of the event.

Embed the verified badge +

This record is in the hand-verified gold set. Copy the snippet below to embed the verified badge on your own site.

<a href="https://unitedwetransform.com/events/evt_2021_aha_scientific_sessions_archive_selected_science_news_from_aha21_profession"><img src="https://unitedwetransform.com/badge/ges-verified.svg" alt="GES verified by United We Transform" height="40"></a>

Where To Go Next

Compare this agenda against other Academic / Research / Science events scored on the same eight pillars.